• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在第3位起始于焦谷氨酸的β淀粉样蛋白是阿尔茨海默病大脑中淀粉样沉积物的主要成分。

Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.

作者信息

Harigaya Y, Saido T C, Eckman C B, Prada C M, Shoji M, Younkin S G

机构信息

Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, Florida 32224, USA.

出版信息

Biochem Biophys Res Commun. 2000 Sep 24;276(2):422-7. doi: 10.1006/bbrc.2000.3490.

DOI:10.1006/bbrc.2000.3490
PMID:11027491
Abstract

The amyloid beta protein (Abeta) deposited in the Alzheimer's disease (AD) brain is heterogeneous at both its amino and carboxyl termini. Recent studies of the genetic forms of AD indicate that the aggregation and deposition of Abeta42 may be a common initiating event in all forms of AD. Here, we analyzed the amino termini of the Abeta species deposited in the AD brain, focusing specifically on species with amino-terminal pyroglutamate at position 3 (Abeta3(pE)). Immunocytochemical analysis of AD brains with an antibody specific for Abeta3(pE) confirmed that these species deposit in blood vessels and senile plaques. Using specific sandwich ELISAs, we determined the amounts of Abeta3(pE)-40 and Abeta3(pE)-42(43) in AD brain compared with other forms. This analysis showed that Abeta3(pE)-40 is closely correlated with the extent of Abeta deposition in blood vessels, whereas Abeta3(pE)-42(43) is not. In addition, Abeta3(pE)-42(43) is an important component of the Abeta deposited in senile plaques of the AD brain, constituting approximately 25% of the total Abeta42(43). In vitro comparison of Abeta1-42 and Abeta3(pE)-42 showed that Abeta3(pE)-42 is highly prone to oligomerization. These findings suggest that Abeta3(pE)-42 may be particularly important in AD pathogenesis.

摘要

沉积在阿尔茨海默病(AD)大脑中的β淀粉样蛋白(Aβ)在其氨基末端和羧基末端均具有异质性。最近对AD遗传形式的研究表明,Aβ42的聚集和沉积可能是所有形式AD的常见起始事件。在此,我们分析了沉积在AD大脑中的Aβ物种的氨基末端,特别关注在第3位具有氨基末端焦谷氨酸的物种(Aβ3(pE))。用对Aβ3(pE)特异的抗体对AD大脑进行免疫细胞化学分析证实,这些物种沉积在血管和老年斑中。使用特异性夹心ELISA,我们测定了与其他形式相比AD大脑中Aβ3(pE)-40和Aβ3(pE)-42(43)的量。该分析表明,Aβ3(pE)-40与血管中Aβ沉积的程度密切相关,而Aβ3(pE)-42(43)则不然。此外,Aβ3(pE)-42(43)是沉积在AD大脑老年斑中的Aβ的重要组成部分,约占总Aβ42(43)的25%。Aβ1-42和Aβ3(pE)-42的体外比较表明,Aβ3(pE)-42极易发生寡聚化。这些发现表明,Aβ3(pE)-42在AD发病机制中可能特别重要。

相似文献

1
Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.在第3位起始于焦谷氨酸的β淀粉样蛋白是阿尔茨海默病大脑中淀粉样沉积物的主要成分。
Biochem Biophys Res Commun. 2000 Sep 24;276(2):422-7. doi: 10.1006/bbrc.2000.3490.
2
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.人源和PS2APP小鼠脑内淀粉样沉积物中β淀粉样肽组成的高灵敏度分析
Neuroscience. 2006 Dec 1;143(2):461-75. doi: 10.1016/j.neuroscience.2006.08.027. Epub 2006 Sep 27.
3
Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.阿尔茨海默病和年轻唐氏综合征大脑中β淀粉样蛋白11-40/42肽沉积的特征:N端截短的β淀粉样蛋白物种在阿尔茨海默病发病机制中的意义。
Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1.
4
Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.在阿尔茨海默病患者大脑的淀粉样斑块核心中,β淀粉样蛋白43比β淀粉样蛋白40更常见。
J Neurochem. 2009 Jul;110(2):697-706. doi: 10.1111/j.1471-4159.2009.06170.x. Epub 2009 May 15.
5
Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.β淀粉样肽1-42与脑毛细血管淀粉样血管病及阿尔茨海默病病理学高度相关。
Acta Neuropathol. 2004 Apr;107(4):283-91. doi: 10.1007/s00401-004-0822-6. Epub 2004 Feb 20.
6
Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.在患有阿尔茨海默病病理的患者大脑中,特定皮质区域内存在丰富的β淀粉样蛋白42阳性毛细血管淀粉样血管病的小区域中,tau蛋白积累相对较少。
Acta Neuropathol. 2006 Jun;111(6):510-8. doi: 10.1007/s00401-006-0070-z. Epub 2006 May 4.
7
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.小鼠淀粉样β蛋白在人APP/PS1双转基因和单转基因阿尔茨海默病模型小鼠中的沉积。
Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10.
8
Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.单体而非寡聚体β淀粉样蛋白的沉积介导了人脑标本中阿尔茨海默病淀粉样斑块的生长。
Biochemistry. 1999 Aug 10;38(32):10424-31. doi: 10.1021/bi990718v.
9
Amyloid-beta aggregation.β-淀粉样蛋白聚集
Neurodegener Dis. 2007;4(1):13-27. doi: 10.1159/000100355.
10
C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.阿尔茨海默病中的C4b结合蛋白:与β淀粉样蛋白1-42及死亡细胞的结合
Mol Immunol. 2008 Aug;45(13):3649-60. doi: 10.1016/j.molimm.2008.04.025. Epub 2008 Jun 16.

引用本文的文献

1
Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer's disease spectrum.化学成像描绘了阿尔茨海默病谱系中的β淀粉样蛋白斑块多态性。
Nat Commun. 2025 Apr 24;16(1):3889. doi: 10.1038/s41467-025-59085-7.
2
Serine phosphorylation mimics of Aβ form distinct, non-cross-seeding fibril morphs.β淀粉样蛋白的丝氨酸磷酸化模拟物形成独特的、非交叉播种的纤维形态。
Chem Sci. 2024 Oct 11;15(45):19142-59. doi: 10.1039/d3sc06343g.
3
Metal Ion Binding to Human Glutaminyl Cyclase: A Structural Perspective.金属离子与人谷氨酰胺酰环化酶的结合:结构视角。
Int J Mol Sci. 2024 Jul 29;25(15):8279. doi: 10.3390/ijms25158279.
4
Cerebral amyloid angiopathy and the immune system.脑淀粉样血管病与免疫系统。
Alzheimers Dement. 2024 Jul;20(7):4999-5008. doi: 10.1002/alz.13826. Epub 2024 Jun 17.
5
Pyroglutamylation modulates electronic properties and the conformational ensemble of the amyloid β-peptide.焦谷氨酸化修饰调节淀粉样β肽的电子性质和构象集合。
Proteins. 2024 Jul;92(7):842-853. doi: 10.1002/prot.26677. Epub 2024 Mar 4.
6
Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions.新兴的阿尔茨海默病治疗方法:来自脂质代谢和以小胶质细胞为重点的干预措施的有前景的见解。
Front Aging Neurosci. 2023 Oct 25;15:1259012. doi: 10.3389/fnagi.2023.1259012. eCollection 2023.
7
Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease.人类谷氨酰胺环化酶抑制剂(QCIs)的开发与演变:一种用于阿尔茨海默病疾病修饰治疗的颇具前景的替代方法。
Front Aging Neurosci. 2023 Aug 3;15:1209863. doi: 10.3389/fnagi.2023.1209863. eCollection 2023.
8
Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer's Disease.新型针对病理性焦谷氨酸化修饰淀粉样β的疫苗,用于预防阿尔茨海默病。
Int J Mol Sci. 2023 Jun 6;24(12):9797. doi: 10.3390/ijms24129797.
9
Alzheimer's Disease and Its Possible Evolutionary Origin: Hypothesis.阿尔茨海默病及其可能的进化起源:假说。
Cells. 2023 Jun 13;12(12):1618. doi: 10.3390/cells12121618.
10
Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.家族性阿尔茨海默病相关突变对淀粉样前体蛋白(APP)转运、蛋白水解转化和突触发生活性的影响差异。
Acta Neuropathol Commun. 2023 Jun 1;11(1):87. doi: 10.1186/s40478-023-01577-y.